QT Imaging Holdings, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $36.8M
- Price
- $2.78
- % Change (Daily % change from the live per-ticker quote feed.)
- -1.42%
- Volume
- 35.8K
About
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
Quick stats
Shares outstanding13.2M
Computed float8.1M
Float / shares60.9%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001844505
Websitehttps://www.qtimaging.com
AI Summary
AI-generated1/39
majorbullishoperations update
QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders
QT Imaging generated $14.0 million in H1 2026 revenue, up 116% year-over-year, and shipped 28 Breast Acoustic CT scanners while maintaining full-year 2026 revenue guidance of approximately $39 million.
The company secured a key reimbursement pathway with AMA approval of a Category III CPT code effective January 2027 and passed its first routine FDA inspection with zero Form 483 observations.
Financially, QT Imaging completed a $10 million public offering and holds $14.2 million in cash, having returned to the Nasdaq Capital Market and joined the Russell Microcap Index.
Red flags
- identified material weakness in internal controls over financial reporting disclosed in risk factors